[go: up one dir, main page]

DK155292D0 - Kemiske forbindelser, deres fremstilling og anvendelse - Google Patents

Kemiske forbindelser, deres fremstilling og anvendelse

Info

Publication number
DK155292D0
DK155292D0 DK921552A DK155292A DK155292D0 DK 155292 D0 DK155292 D0 DK 155292D0 DK 921552 A DK921552 A DK 921552A DK 155292 A DK155292 A DK 155292A DK 155292 D0 DK155292 D0 DK 155292D0
Authority
DK
Denmark
Prior art keywords
preparation
chemical compounds
compounds
chemical
Prior art date
Application number
DK921552A
Other languages
Danish (da)
English (en)
Inventor
Nordisk A S Novo
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK921552A priority Critical patent/DK155292D0/da
Publication of DK155292D0 publication Critical patent/DK155292D0/da
Priority to US08/169,097 priority patent/US5484774A/en
Priority to IL10811993A priority patent/IL108119A0/xx
Priority to CA002152341A priority patent/CA2152341A1/en
Priority to SK826-95A priority patent/SK82695A3/sk
Priority to CZ951642A priority patent/CZ164295A3/cs
Priority to NZ259323A priority patent/NZ259323A/en
Priority to PL93309610A priority patent/PL175029B1/pl
Priority to JP6514703A priority patent/JPH08504777A/ja
Priority to AU58093/94A priority patent/AU690532B2/en
Priority to PCT/DK1993/000434 priority patent/WO1994014832A1/en
Priority to HU9501856A priority patent/HUT72409A/hu
Priority to EP94903747A priority patent/EP0675896A1/en
Priority to KR1019950702609A priority patent/KR960700260A/ko
Priority to ZA939663A priority patent/ZA939663B/xx
Priority to FI953127A priority patent/FI953127L/fi
Priority to NO952508A priority patent/NO952508L/no
Priority to BG99741A priority patent/BG61607B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK921552A 1992-12-23 1992-12-23 Kemiske forbindelser, deres fremstilling og anvendelse DK155292D0 (da)

Priority Applications (18)

Application Number Priority Date Filing Date Title
DK921552A DK155292D0 (da) 1992-12-23 1992-12-23 Kemiske forbindelser, deres fremstilling og anvendelse
US08/169,097 US5484774A (en) 1992-12-23 1993-12-17 2, N6 -disubstituted adenosines, tri-O-ester derivatives and their pharmaceutical compositions to treat ischemias
KR1019950702609A KR960700260A (ko) 1992-12-23 1993-12-21 퓨린 유도체(Purine derivatives)
JP6514703A JPH08504777A (ja) 1992-12-23 1993-12-21 プリン誘導体
AU58093/94A AU690532B2 (en) 1992-12-23 1993-12-21 Purine derivatives
SK826-95A SK82695A3 (en) 1992-12-23 1993-12-21 Purine derivatives
CZ951642A CZ164295A3 (en) 1992-12-23 1993-12-21 Purine derivatives
NZ259323A NZ259323A (en) 1992-12-23 1993-12-21 N-substituted adenosine derivatives, preparation and pharmaceutical compositions thereof
PL93309610A PL175029B1 (pl) 1992-12-23 1993-12-21 Pochodne puryny oraz kompozycje farmaceutyczne zawierające pochodne puryny
IL10811993A IL108119A0 (en) 1992-12-23 1993-12-21 Purine derivatives their preparation and pharmaceutical compositions containing them
CA002152341A CA2152341A1 (en) 1992-12-23 1993-12-21 Purine derivatives
PCT/DK1993/000434 WO1994014832A1 (en) 1992-12-23 1993-12-21 Purine derivatives
HU9501856A HUT72409A (en) 1992-12-23 1993-12-21 Purine derivatives, their preparation and application
EP94903747A EP0675896A1 (en) 1992-12-23 1993-12-21 Purine derivatives
ZA939663A ZA939663B (en) 1992-12-23 1993-12-23 Chemical compounds their preparation and use
FI953127A FI953127L (fi) 1992-12-23 1995-06-22 Puriinijohdannaisia
NO952508A NO952508L (no) 1992-12-23 1995-06-22 Purinderivater
BG99741A BG61607B1 (bg) 1992-12-23 1995-06-22 Пуринови производни

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK921552A DK155292D0 (da) 1992-12-23 1992-12-23 Kemiske forbindelser, deres fremstilling og anvendelse

Publications (1)

Publication Number Publication Date
DK155292D0 true DK155292D0 (da) 1992-12-23

Family

ID=8105999

Family Applications (1)

Application Number Title Priority Date Filing Date
DK921552A DK155292D0 (da) 1992-12-23 1992-12-23 Kemiske forbindelser, deres fremstilling og anvendelse

Country Status (18)

Country Link
US (1) US5484774A (cs)
EP (1) EP0675896A1 (cs)
JP (1) JPH08504777A (cs)
KR (1) KR960700260A (cs)
AU (1) AU690532B2 (cs)
BG (1) BG61607B1 (cs)
CA (1) CA2152341A1 (cs)
CZ (1) CZ164295A3 (cs)
DK (1) DK155292D0 (cs)
FI (1) FI953127L (cs)
HU (1) HUT72409A (cs)
IL (1) IL108119A0 (cs)
NO (1) NO952508L (cs)
NZ (1) NZ259323A (cs)
PL (1) PL175029B1 (cs)
SK (1) SK82695A3 (cs)
WO (1) WO1994014832A1 (cs)
ZA (1) ZA939663B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683989A (en) * 1993-12-17 1997-11-04 Novo Nordisk A/S Treatment of ischemias by administration of 2,N6 -substituted adenosines
WO1997037667A1 (en) * 1996-04-10 1997-10-16 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of an a1 adenosine receptor agonist to treat cerebral ischaemia
GB9610031D0 (en) * 1996-05-14 1996-07-17 Glaxo Group Ltd Chemical compounds
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
GB9913932D0 (en) 1999-06-15 1999-08-18 Pfizer Ltd Purine derivatives
JP2001163854A (ja) * 1999-09-28 2001-06-19 Nippon Nohyaku Co Ltd チオアルキルアミン誘導体及びその製造方法
US7342003B2 (en) * 2001-10-25 2008-03-11 King Pharmaceuticals Research And Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
US20110087015A1 (en) * 2003-09-10 2011-04-14 Riken Nucleoside and nucleotide having an unnatural base and use thereof
WO2005033121A2 (en) * 2003-10-03 2005-04-14 King Pharmaceuticals Research & Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
CN101041637B (zh) * 2007-04-29 2010-06-09 浙江工业大学 含咪唑硫醚结构的手性胺质子酸盐及其制备方法与应用
CN101041638B (zh) * 2007-04-29 2010-05-26 浙江工业大学 含咪唑硫醚结构的手性胺及其制备方法与应用
CN105273027B (zh) * 2014-07-22 2018-11-06 上海医药工业研究院 坎格雷洛中间体及其制备方法和应用
CN105273025B (zh) * 2014-07-22 2019-07-26 上海医药工业研究院 一种制备坎格雷洛的中间体及其制备方法和应用
CN105273026B (zh) * 2014-07-22 2018-11-06 上海医药工业研究院 一种药物中间体及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
EP0300144A3 (en) * 1984-04-18 1989-09-27 Whitby Research Incorporated N-6 alkyl substituted adenosine derivatives as cardiac vasodilators
EP0423777A3 (en) * 1989-10-19 1991-09-25 G.D. Searle & Co. Method of treating gastrointestinal motility disorders
US5055569A (en) * 1989-10-19 1991-10-08 G. D. Searle & Co. N-(6)-substituted adenosine compounds
EP0550631B1 (en) * 1990-09-25 1997-01-02 Rhone-Poulenc Rorer International (Holdings) Inc. Compounds having antihypertensive and anti-ischemic properties
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
DK62692D0 (cs) * 1992-05-14 1992-05-14 Novo Nordisk As
WO1994002497A1 (en) * 1992-07-15 1994-02-03 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Sulfo-derivatives of adenosine

Also Published As

Publication number Publication date
BG61607B1 (bg) 1998-01-30
NZ259323A (en) 1996-06-25
IL108119A0 (en) 1994-04-12
FI953127L (fi) 1995-08-21
ZA939663B (en) 1995-06-23
CZ164295A3 (en) 1996-01-17
US5484774A (en) 1996-01-16
FI953127A0 (fi) 1995-06-22
WO1994014832A1 (en) 1994-07-07
EP0675896A1 (en) 1995-10-11
NO952508L (no) 1995-08-22
KR960700260A (ko) 1996-01-19
NO952508D0 (no) 1995-06-22
BG99741A (bg) 1996-04-30
AU690532B2 (en) 1998-04-30
JPH08504777A (ja) 1996-05-21
AU5809394A (en) 1994-07-19
CA2152341A1 (en) 1994-07-07
HU9501856D0 (en) 1995-08-28
HUT72409A (en) 1996-04-29
SK82695A3 (en) 1996-04-03
PL309610A1 (en) 1995-10-30
PL175029B1 (pl) 1998-10-30

Similar Documents

Publication Publication Date Title
NO961071D0 (no) Kjemiske forbindelser, deres fremstilling og anvendelse
NO933434D0 (no) Piperidinderivater, deres fremstilling og anvendelse
NO961160D0 (no) Cykliske forbindelser, deres fremstilling og anvendelse
NO177751C (no) Piperidinsubstituerte polysiloksanforbindelser, deres fremstilling og anvendelse
DK155292D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DK371088A (da) Azacykliske forbindelser, deres fremstilling og anvendelse
DK60593D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
NO903978D0 (no) Pyridinyl-kinolonforbindelser, deres fremstilling og bruk.
NO941517L (no) 2-amino-4-kinolin-dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
NO933435D0 (no) Piperidinderivater, deres fremstilling og anvendelse
NO934633D0 (no) Kondenserte, heterocykliske forbindelser, deres fremstilling og anvendelse
DK60693D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DK73091D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
NO922992D0 (no) Imid-terminerte polynitrogenforbindelser, deres fremstilling og anvendelse
NO308213B1 (no) Substituerte indanylidinacetylguanidiner, deres anvendelse og medikamenter inneholdende forbindelsene
DK60493D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DK83988D0 (da) Pesticide forbindelser, deres fremstilling og midler indeholdende forbindelserne
DK86592D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DK71092D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DK155392D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DK104393D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
DK93593D0 (da) Kemiske forbindelser, deres fremstilling og anvendelse
NO920228L (no) Polylaktider, deres fremstilling og anvendelse
NO923194D0 (no) Substituerte urea-forbindelser, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
A0 Application filed
PBP Patent lapsed
AHS Application shelved for other reasons than non-payment